Resource data sheet
DNA Bank Top
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pCMFlag_hsCREB1, transcript variant A (#RDB07501)

Expression vector of human CREB1.

Alternative name SET-0020_8-1
Clone info. Expression vector of human CREB1. Expression has not yet been confirmed.
Comment PCR cloning, forward primer: ATGACCATGGAATCTGGAGCCGA; reverse primer: AATTAATCTGATTTGTGGCAGTAAA.
Vector backbone pCMV_S-FLAG (RDB05956) (Plasmid)
Selectable markers Amp^r (E. coli), Neo^r (mammalian cell)
Growth conditions 37C, LB+Amp
Gene/insert name Human CREB1,transcript variant A cDNA
Depositor|Developer DNA Bank, |
 

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms
Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ]
MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ]
MTA, for use for for-profit purpose [Word]
Please visit Information of Request for Distribution.[link] 
Terms and conditions for distribution The RECIPIENT agrees to describe RIKEN BRC as the source of the MATERIAL in any publication.
Additional terms and conditions:
Regrding pRc/CMV:
a) The modified pRc/CMV, and their descendants (collectively, LIFE MATERIALS), should be used for pre-clinical/non-human, research use only.
b) LIFE MATERIALS shall not be used for any commercial purposes.
c) LIFE MATERIALS shall not be transferred beyond the specified recipient.
d) Recipient must contact Thermo Fisher Scientific Inc. at outlicense@thermofisher.com for any desired use of LIFE MATERIALS beyond the scope of a) to c) above.
提供案内 (日本国内) [open/close]

必要書類
提供依頼書  [依頼書の記入例 ]
提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ]
提供同意書 (MTA, 営利目的用)[Word]
手続きの概要は、「提供申込みについて[link]」をご覧ください。
MTAに書く使用条件 発表に際し、理研BRCから入手したことを明記すること。
付加的使用条件:
pRc/CMVについて:
a) The modified pRc/CMV, and their descendants (collectively, LIFE MATERIALS), should be used for pre-clinical/non-human, research use only.
b) LIFE MATERIALS shall not be used for any commercial purposes.
c) LIFE MATERIALS shall not be transferred beyond the specified recipient.
d) Recipient must contact Thermo Fisher Scientific Inc. at outlicense@thermofisher.com for any desired use of LIFE MATERIALS beyond the scope of a) to c) above.

Catalog # Resource name Shipping form Fee
RDB07501 pCMFlag_hsCREB1, transcript variant A DNA solution JPY 9,460 (not-for-profit academic purpose)
JPY 18,920 (for-profit-research purpose)
plus cost of shipping containers, dry ice (if required) and shipping charge

Please review the QC test results indicated by check icon below as well as clone information before placing your order.

How to cite this biological resource

Materials & Methods section:

The pCMFlag_hsCREB1, transcript variant A was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07501).

Reference section:

Further references such as user reports and related articles (go to bottom)


QC test results

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by check icon as well as clone information before placing your order.

Test sheet RDB07501_A1L1p1-1.pdf check

Nucleotide sequence of a portion of this resource (if available).

Primer: CMV_Forward (Pr0016)
Region: CMV pro,FLAG,insert 5'
Sequence file: RDB07501_A1L1a.seq check
>07501_07501_B1AjF_CMV-Forward_E10_13_ABI24.ab1
    1 NNNNNNNNNN NNNNNTNGNN NNNNNNGGGC GGTAGGCGTG TACGGTGGGA GGTCTATATA
   61 AGCAGAGCTC TCTGGCTAAC TAGAGAACCC ACTGCTTACT GGCTTATCGA AATTAATACG
  121 ACTCACTATA GGGAGACCCA AGCTGAATTC ACCATGGACT ACAAGGACGA TGACGATAAG
  181 GCGGCCATGA CCATGGAATC TGGAGCCGAG AACCAGCAGA GTGGAGATGC AGCTGTAACA
  241 GAAGCTGAAA ACCAACAAAT GACAGTTCAA GCCCAGCCAC AGATTGCCAC ATTAGCCCAG
  301 GTATCTATGC CAGCAGCTCA TGCAACATCA TCTGCTCCCA CCGTAACTCT AGTACAGCTG
  361 CCCAATGGGC AGACAGTTCA AGTCCATGGA GTCATTCAGG CGGCCCAGCC ATCAGTTATT
  421 CAGTCTCCAC AAGTCCAAAC AGTTCAGATT TCAACTATTG CAGAAAGTGA AGATTCACAG
  481 GAGTCAGTGG ATAGTGTAAC TGATTCCCAA AAGCGAAGGG AAATTCTTTC AAGGAGGCCT
  541 TCCTACAGGA AAATTTTGAA TGACTTATCT TCTGATGCAC CAGGAGTGCC AAGGNNTGAA
  601 GAAGAGAAGT CTGAANAGGA NANTTCNGCA CCTGCCNTCA CCACTGNNAC GGTGCNNACT
  661 CCNATTTACC NAACTNGCAG TGGNNAGNAT ATNGNNNTNA CCNNNGGNNN ANNNNNNNNC
721 NNGNNNNNNN NNN
//
Primer: bGH_rev3 (Pr0885)
Region: bGHpA,insert 3'
Sequence file: RDB07501_A1L1b.seq check
>07501_07501_B1AjF_bGH_rev3_E11_14_ABI24.ab1
    1 NNNNNNNNNN NNNNNNGNNG NNGGGCANAC AANNGATGGC TGGCAACTAG AAGGCACAGT
   61 CGAGGCTGAT CAGCGAGCTC TAGCATTTAG GTGACACTAT AGAATAGGGC CCTCTAGATG
  121 CATGCTCGAG CGGCCAATTA ATCTGATTTG TGGCAGTAAA GGTCCTTAAG TGCTTTTAGC
  181 TCCTCAATCA ATGTCTTGTT TTGATTTTCA AGCACTGCCA CTCTGTTTTC TAAACATTTC
  241 ACATATTCTT TCTTCTTTCT ACGACACTCT CGAGCTGCTT CCCTGTTCTT CATTAGACGG
  301 ACCTCTCTCT TTCGTGCTGC TTCTTCAGCA GGCTGTGTAG GAAGTGCTGG GGAGGATGCC
  361 ATAACAACTC CAGGGGCAAT AGTGCTAGTG GGTGCTGTGC GAATCTGGTA TGTTTGTACG
  421 TCTCCAGAGG CAGCTTGAAC AACAACTTGG TTGCTGGGCA CTAAGATCTG CTGTCCATCA
  481 GTGGTCTGTG CATACTGTAG AATGGTAGTA CCCGGCTGAG TGGCTGCTGC ATTGGTCATG
  541 GTTAATGTTT GCAGGCCCTG TACCCCATCG GTACCATTGT TAGCCAGCTG TATTGCTCCT
  601 CCCTGGGTAA TGGCAATATA CTGTCCACTG CTAGTTTGGT AAATTGGAGT TGGCANCGTT
  661 ACAGTGGTGA NGGCANGNGC TGNANTCTCC TCNTCNNANT NCTCNNCNNC NNNNNNNNNN
//
Primer: SV40pro_ori_F (Pr0731)
Region: SV40 pro_ori,NeoR
Sequence file: RDB07501_A1L1c.seq check
>07501_07501_B1AjF_SV40pro_ori_F_E12_15_ABI24.ab1
    1 NNNNNNNNNC NNNGCCGCCT CGGCCTCTGA NCTATTCCNG AAGTAGTGAG GAGGCTTTTT
   61 TGGAGGCCTA GGCTTTTGCA AAAAGCTCCC GGGAGCTTGG ATATCCATTT TCGGATCTGA
  121 TCAAGAGACA GGATGAGGAT CGTTTCGCAT GATTGAACAA GATGGATTGC ACGCAGGTTC
  181 TCCGGCCGCT TGGGTGGAGA GGCTATTCGG CTATGACTGG GCACAACAGA CAATCGGCTG
  241 CTCTGATGCC GCCGTGTTCC GGCTGTCAGC GCAGGGGCGC CCGGTTCTTT TTGTCAAGAC
  301 CGACCTGTCC GGTGCCCTGA ATGAACTGCA GGACGAGGCA GCGCGGCTAT CGTGGCTGGC
  361 CACGACGGGC GTTCCTTGCG CAGCTGTGCT CGACGTTGTC ACTGAAGCGG GAAGGGACTG
  421 GCTGCTATTG GGCGAAGTGC CGGGGCAGGA TCTCCTGTCA TCTCACCTTG CTCCTGCCGA
  481 GAAAGTATCC ATCATGGCTG ATGCAATGCG GCGGCTGCAT ACGCTTGATC CGGCTACCTG
  541 CCCATTCGAC CACCAAGCGA AACATCGCAT CGAGCGAGCA CGTACTCGGA TGGAAGCCGG
  601 TCTTGTCNAT CANGANGANC TGGANNAANA NCATCNNGGG CTCGCGNCNG CCNAACTGNT
  661 CGCCNGGCTC NANGNNCNNA NGNCCNANNN NAGNNNCNCN NCNNGNNCNN NNNNNANGNN
721 NGNNNGNNNA ANANNNNNNN NNN
//

Please visit Sequencing and PCR primers for primer information.


References

Original, user report and related articles